2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1

Kuchulukirachulukira koyang'anira mapulojekiti komanso mtundu umodzi kapena umodzi wopereka chithandizo kumapangitsa kufunikira kwa kulumikizana kwa bungwe komanso kumvetsetsa kwathu zomwe mukuyembekezera mu 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1, We ali okonzeka kukupatsani mtengo wotsika kwambiri pamsika, wabwino kwambiri komanso ntchito yabwino yogulitsa.Mwalandiridwa kuti muchite ma bussines nafe, tiyeni tipambane pawiri.
Kuchulukirachulukira koyang'anira ma projekiti komanso mtundu umodzi wokha wa opereka chithandizo kumapangitsa kufunikira kolumikizana ndi bungwe komanso kumvetsetsa kwathu zoyembekeza zanu.China 3-Aminopyrazine-2-Carboxylic Acid ndi 5424-01-1, Katundu wathu ndi wotchuka kwambiri m'mawu, monga South America, Africa, Asia ndi zina zotero.Makampani "kupanga zinthu zapamwamba" monga cholinga, ndikuyesetsa kupereka makasitomala ndi mayankho apamwamba, kupereka chithandizo chapamwamba pambuyo pa malonda ndi chithandizo chaumisiri, ndi kupindula kwamakasitomala, kupanga ntchito yabwino ndi tsogolo labwino!

2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid amagwiritsidwa ntchito ngati wapakatikati wa Eltrombopag.
Eltrombopag, yopangidwa ndi GlaxoSmithKline (GSK) ku UK ndipo pambuyo pake idapangidwa limodzi ndi Novartis ku Switzerland, ndiye woyamba komanso wovomerezeka wa agonist ang'onoang'ono omwe si peptide TPO receptor agonist padziko lapansi.Eltrombopag idavomerezedwa ndi US FDA mu 2008 pochiza idiopathic thrombocytopenic purpura (ITP), komanso mu 2014 pochiza aplastic anemia (AA).Ndiwonso mankhwala oyamba ovomerezedwa ndi US FDA pochiza AA m'zaka 30 zaposachedwa.
Mu december2012, US FDA inavomereza Eltrombopag zochizira thrombocytopenia odwala matenda a chiwindi C (CHC), kuti odwala matenda a chiwindi C ndi osauka matenda chifukwa otsika kupatsidwa zinthu za m`mwazi kuwerenga akhoza kuyamba ndi kusunga interferon zochokera muyezo mankhwala kwa matenda a chiwindi.Pa february3, 2014, GlaxoSmithKline adalengeza kuti FDA idapereka chithandizo chamankhwala chopambana cha Eltrombopag pochiza hemopenia kwa odwala omwe ali ndi chemicalbook aplastic anemia (SAA) omwe sanayankhe mokwanira ku immunotherapy.Pa Ogasiti 24, 2015, US FDA idavomereza Eltrombopag kuti azichiza thrombocytopenia mwa akulu ndi ana azaka za 1 ndi kupitilira omwe ali ndi matenda osachiritsika a immune thrombocytopenia (ITP) omwe alibe yankho lokwanira ku corticosteroids, immunoglobulins kapena splenectomy.Pa january4, 2018, Eltrombopag idavomerezedwa kuti ilembedwe ku China kuti ichiritse primary immune thrombocytopenia (ITP).

Kuchulukirachulukira koyang'anira mapulojekiti komanso mtundu umodzi kapena umodzi wopereka chithandizo kumapangitsa kufunikira kwa kulumikizana kwa bungwe komanso kumvetsetsa kwathu zomwe mukuyembekezera mu 2019 New Style 3-Aminopyrazine-2-Carboxylic Acid CAS No. 5424-01-1, We ali okonzeka kukupatsani mtengo wotsika kwambiri pamsika, wabwino kwambiri komanso ntchito yabwino yogulitsa.Mwalandiridwa kuti muchite ma bussines nafe, tiyeni tipambane pawiri.
2019 Mtundu WatsopanoChina 3-Aminopyrazine-2-Carboxylic Acid ndi 5424-01-1, Katundu wathu ndi wotchuka kwambiri m'mawu, monga South America, Africa, Asia ndi zina zotero.Makampani "kupanga zinthu zapamwamba" monga cholinga, ndikuyesetsa kupereka makasitomala ndi mayankho apamwamba, kupereka chithandizo chapamwamba pambuyo pa malonda ndi chithandizo chaumisiri, ndi kupindula kwamakasitomala, kupanga ntchito yabwino ndi tsogolo labwino!